Selim Cellek

Selim Cellek is Professor of Health and Biomedicine at Anglia Ruskin University (ARU), where he leads the Drug Discovery Group within the Medical Technology Research Centre (MTRC). He is affiliated with the Faculty of Health, Medicine and Social Care, specifically the School of Allied Health and Social Care. His research bridges pharmacology, urology, and translational medicine.

Education:

• MD, Hacettepe University
• PhD Pharmacology, University of London

Research Focus: Professor Cellek specializes in phenotypic drug discovery, fibroproliferative diseases, and urogenital pathophysiology. Key areas include diabetic autonomic neuropathy, Peyronie’s disease, nitrergic neurotransmission, and the development of cell-based assays for novel therapeutics.

Publication Trends: His 15 most recent articles (2009–2015) concentrate on urogenital disorders (erectile dysfunction, Peyronie’s disease), diabetic complications, and gastrointestinal pharmacology. Methodologically, they emphasize translational models, drug discovery assays, and neurovascular mechanisms.

Awards & Fellowships:

• Fellowship, British Pharmacological Society
• Fellowship, European Society for Sexual Medicine

Professional Engagement: He consults for the pharmaceutical industry on drug development for urogenital, gastrointestinal, and diabetic neuropathy indications.